Berenberg Bank Initiates Smith & Nephew(SNN.US) With Hold Rating, Announces Target Price $27.27
Smith & Nephew (SN) Gets a Buy From RBC Capital
BofA Securities Maintains Smith & Nephew(SNN.US) With Buy Rating
CCORF Maintains Smith & Nephew(SNN.US) With Hold Rating, Maintains Target Price $32
Smith & Nephew Cut to Hold From Buy by Deutsche Bank
Smith & Nephew Target Cut to GBP12.50 From GBP13.50 by Deutsche Bank
Smith & Nephew (SN) Gets a Hold From Barclays
BofA Securities Initiates Smith & Nephew(SNN.US) With Buy Rating
Buy Rating on Smith & Nephew: Turnaround, Growth, and Margin Improvement Prospects
Smith & Nephew (SN) Gets a Buy From RBC Capital
Barclays Sticks to Their Hold Rating for Smith & Nephew (SN)
Smith & Nephew (SN) Receives a Buy From UBS
RBC Capital Sticks to Its Buy Rating for Smith & Nephew (SN)
Smith & Nephew Analyst Ratings
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc
Analysts Offer Insights on Healthcare Companies: Smith & Nephew Snats (SNN), Ocuphire Pharma (OCUP) and Vertex Pharmaceuticals (VRTX)
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc
Balanced Outlook: Hold Rating Justified for Smith & Nephew Amidst Growth and Market Challenges
Analysts Offer Insights on Healthcare Companies: Liquidia Technologies (LQDA), TELA Bio (TELA) and Smith & Nephew Snats (SNN)
Research Alert: CFRA Keeps Hold Opinion On Adss Of Smith & Nephew Plc